The economics of the vaccine: Who wins and who loses?

Michael Takudzwa Pasara ()
Additional contact information
Michael Takudzwa Pasara: North-West University

Africagrowth Agenda, 2021, vol. 18, issue 2, 6-10

Abstract: This article raises questions to the pertinent issues surrounding the virus and the vaccine. While the coronavirus pandemic is both a health and economic shock which requires urgent attention, this paper attempts to not only provide the rationale for the vaccination rollout such as negative externalities but also shed light into some of the existing loopholes within the systems which can be exploited especially by multinational corporations. They are mainly driven by the profit maximisation motive but could simultaneously leave a trail of irreversible damages along the way. There is scepticism surrounding the research models with some arguing that the time was simply too short for it to be administered to people on such a large scale. Potential adverse effects of vaccines are usually recognised in the long term. As the global community seek for a solution, whether it is a vaccine or some other form, the author argues that care should always be taken by governments to correct for market imperfections which can result in economic exploitation for to some, ‘Within chaos, lies opportunity.’ Could someone be taking advantage of this chaos?

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://journals.co.za/doi/abs/10.10520/ejc-afgrow-v18-n2-a2 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:afj:journ2:v:18:y:2021:i:2:p:6-10

Access Statistics for this article

More articles in Africagrowth Agenda from Africagrowth Institute Contact information at EDIRC.
Bibliographic data for series maintained by Kirk De Doncker ().